172 related articles for article (PubMed ID: 22584056)
1. Protein translocation as a tool: The current rapamycin story.
Putyrski M; Schultz C
FEBS Lett; 2012 Jul; 586(15):2097-105. PubMed ID: 22584056
[TBL] [Abstract][Full Text] [Related]
2. Rapamycin: something old, something new, sometimes borrowed and now renewed.
Hartford CM; Ratain MJ
Clin Pharmacol Ther; 2007 Oct; 82(4):381-8. PubMed ID: 17728765
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in the chemistry, biosynthesis and pharmacology of rapamycin analogs.
Graziani EI
Nat Prod Rep; 2009 May; 26(5):602-9. PubMed ID: 19387497
[TBL] [Abstract][Full Text] [Related]
4. Rapamycin induces the TGFbeta1/Smad signaling cascade in renal mesangial cells upstream of mTOR.
Osman B; Doller A; Akool el-S; Holdener M; Hintermann E; Pfeilschifter J; Eberhardt W
Cell Signal; 2009 Dec; 21(12):1806-17. PubMed ID: 19666112
[TBL] [Abstract][Full Text] [Related]
5. Rapamycin confers preconditioning-like protection against ischemia-reperfusion injury in isolated mouse heart and cardiomyocytes.
Khan S; Salloum F; Das A; Xi L; Vetrovec GW; Kukreja RC
J Mol Cell Cardiol; 2006 Aug; 41(2):256-64. PubMed ID: 16769083
[TBL] [Abstract][Full Text] [Related]
6. Rapamycin causes activation of protein phosphatase-2A1 and nuclear translocation of PCNA in CD4+ T cells.
Morrow PW; Tung HY; Hemmings HC
Biochem Biophys Res Commun; 2004 Oct; 323(2):645-51. PubMed ID: 15369799
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of rapamycin-induced cell death.
Galluzzi L; Morselli E; Kepp O; Vitale I; Younes AB; Maiuri MC; Kroemer G
Methods Mol Biol; 2012; 821():125-69. PubMed ID: 22125064
[TBL] [Abstract][Full Text] [Related]
8. Isolation from pig liver microsomes, identification by tandem mass spectrometry and in vitro immunosuppressive activity of an SDZ-RAD 17,18,19,20,21,22-tris-epoxide.
Lhoëst GJ; Gougnard TY; Verbeeck RK; Maton N; Dehoux JP; Wallemacq P; Schüler W; Latinne D
J Mass Spectrom; 2000 Mar; 35(3):454-60. PubMed ID: 10767777
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin (sirolimus): a two-edged sword?
J Gross G
J Mol Cell Cardiol; 2006 Aug; 41(2):226-7. PubMed ID: 16781729
[No Abstract] [Full Text] [Related]
10. Late conversion to mammalian target of rapamycin inhibitor/proliferation signal inhibitors in kidney transplant patients: clinical experience in the last 5 years.
Sola E; Lopez V; Gutierrez C; Cabello M; Burgos D; Molina MG; Hernandez D
Transplant Proc; 2010 Oct; 42(8):2859-60. PubMed ID: 20970551
[TBL] [Abstract][Full Text] [Related]
11. The rapamycin-sensitive signal transduction pathway as a target for cancer therapy.
Hidalgo M; Rowinsky EK
Oncogene; 2000 Dec; 19(56):6680-6. PubMed ID: 11426655
[TBL] [Abstract][Full Text] [Related]
12. Antifungal rapamycin analogues with reduced immunosuppressive activity.
Dickman DA; Ding H; Li Q; Nilius AM; Balli DJ; Ballaron SJ; Trevillyan JM; Smith ML; Seif LS; Kim K; Sarthy A; Goldman RC; Plattner JJ; Bennani YL
Bioorg Med Chem Lett; 2000 Jul; 10(13):1405-8. PubMed ID: 10888319
[TBL] [Abstract][Full Text] [Related]
13. Mammalian target of rapamycin is a promising target for novel therapeutic strategy against cancer.
Bjelogrlić SK; Srdić T; Radulović S
J BUON; 2006; 11(3):267-76. PubMed ID: 17309148
[TBL] [Abstract][Full Text] [Related]
14. mTOR regulates expression of slit diaphragm proteins and cytoskeleton structure in podocytes.
Vollenbröker B; George B; Wolfgart M; Saleem MA; Pavenstädt H; Weide T
Am J Physiol Renal Physiol; 2009 Feb; 296(2):F418-26. PubMed ID: 19019920
[TBL] [Abstract][Full Text] [Related]
15. Rapamycin: an anti-cancer immunosuppressant?
Law BK
Crit Rev Oncol Hematol; 2005 Oct; 56(1):47-60. PubMed ID: 16039868
[TBL] [Abstract][Full Text] [Related]
16. Effect of immunosuppressive agents on glucocorticoid receptor function in A6 cells.
Edinger RS; Watkins SC; Pearce D; Johnson JP
Am J Physiol Renal Physiol; 2002 Aug; 283(2):F254-61. PubMed ID: 12110508
[TBL] [Abstract][Full Text] [Related]
17. [Rapamycin and CCI-779].
Alexandre J; Raymond E; Armand JP
Bull Cancer; 1999 Oct; 86(10):808-11. PubMed ID: 10572230
[TBL] [Abstract][Full Text] [Related]
18. Phosphatidic acid-mediated mitogenic activation of mTOR signaling.
Fang Y; Vilella-Bach M; Bachmann R; Flanigan A; Chen J
Science; 2001 Nov; 294(5548):1942-5. PubMed ID: 11729323
[TBL] [Abstract][Full Text] [Related]
19. Sirolimus and everolimus reduce albumin endocytosis in proximal tubule cells via an angiotensin II-dependent pathway.
Oroszlán M; Bieri M; Ligeti N; Farkas A; Meier B; Marti HP; Mohacsi P
Transpl Immunol; 2010 Jul; 23(3):125-32. PubMed ID: 20470887
[TBL] [Abstract][Full Text] [Related]
20. Potential role of proliferation signal inhibitors on atherosclerosis in renal transplant patients.
Andrés V; Castro C; Campistol JM
Nephrol Dial Transplant; 2006 Jul; 21 Suppl 3():iii14-7. PubMed ID: 16815851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
